Orthopedic Biomaterials Market by Material (Ceramics & Bioactive Glasses, Metal, Calcium Phosphate Cement, Polymers, and Others), Application (Bio-resorbable Tissue Fixation, Orthopedic Implants, Joint Replacement/Reconstruction, Orthobiologics, Viscosupplementation, and Others), End-user (Specialty Clinics, Hospitals, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023– 2031

The global orthopedic biomaterials market size was USD 15.5 Bn in 2022 and is likely to reach USD 38.7 Bn by 2031, expanding at a CAGR of 10.4% during 2023–2031. The market growth is attributed to an increase in the geriatric population, increasing musculoskeletal disorders, accidental injuries, and growing incidences of sports injuries.

Orthopedic biomaterials are artificial supporting materials used for joint replacement, reinforcement for fractures, spinal supportive products, and arthroscopy implant materials. Orthopedics is a branch of medicine dealing with musculoskeletal ailments and disorders of the muscles, bones, and joints. Supports for tissue repair, tissue substitutes, and bone repair have constituents as orthopedic biomaterials.

Orthopedic biomaterials exhibit properties such as hardness to fractures, strength, ductility, stretchability, biocompatibility, and corrosion resistance.  These properties are preferred for increasing the load-bearing surface capacities of biomaterials in fixation procedures. Affected joints and bones are provided with adequate support through bioimplants. Enhanced biocompatibility with the human body is leading to the extensive use of orthopedic biomaterials.

COVID-19 Impact on Orthopedic Biomaterials Market

The market report finds that the COVID-19 pandemic adversely affected the global orthopedic biomaterials market, due to decreased footfalls of patients around the world for orthopedic treatments. The demand for orthopedic materials reduced considerably during the pandemic period. Non-essential expenses by consumers reduced significantly during the pandemic with changes in economic conditions and budgets of individuals affecting the growth of the orthopedic biomaterials industry.

Orthopedic Biomaterials Market Dynamics

The research report presents a complete market overview by providing detailed information about the current market trends, existing drivers, growth opportunities and potentials, and emerging challenges. The global orthopedic biomaterials market report has up-to-date insights about market scenarios that can shape the overall market performance and output during the forecast period, 2023 to 2031.

What are the Drivers of Orthopedic Biomaterials Market?

Increasing Geriatric Population

The geriatric population opting for biomaterials in orthopedic implanting procedures is on the rise which has boosted the growth of the global orthopedic biomaterials market. Modernized medical research methodology has made it possible to provide one-time solutions for orthopedic ailments. medical facilities are preferred by older adults for curing orthopedic ailments over repeated visits to hospitals and clinics.

The use of orthopedic biomaterials in procedures such as bio-implants reduces lengthy medical treatments which are desired by the geriatric population. Chronic problems faced by the elderly are related to joint movements. Biomaterial implants lend support for knee, joint, and hip troubles. Orthopedic biomaterial implants provide instant relief through knee replacement and joint & hip fixation. 

Growing Use in Sports Medicine

Rising sports activities around the world are boosting the number of young athletes. A flip side of the increased sporting activities has been a proportional upsurge in the number of sports injuries, driving the market growth of orthopedic device usage.

Sports injuries such as stress fractures and pulled muscles are commonly treated through sports medicine. Biomaterials are used as implants for treating musculoskeletal ailments of muscles, tendons, bones, cartilage, joints, and ligaments.

What are the Restraints of Orthopedic Biomaterials Market?

Rejection and Allergic Reactions of the Body

Implanted orthopedic materials can be rejected by the body causing strong allergic reactions. This factor can be one of the major restraints to the market growth in the coming years. Surface contamination of implants is responsible for spreading infections in the area of the implant. Reaction indications ranging from rashes to swellings have restrained the wide use of biomaterials.

Cases of implanted material intolerance by the human body have been found, causing severe pain in joints, tissue edema, and recurring effusion. Soreness and stiffness in joints have been reported as well. This is a major reason that may hamper the progress of the orthopedic biomaterials industry.

Which are the Opportunities in Orthopedic Biomaterials Market?

Advancements in Implant Technology

Major companies in healthcare manufacturing invest heavily in research & development to introduce better treatment resources for their consumers increasing the opportunities for market growth. Persistent R&D programs generate opportunities for introducing advanced biomaterial products.

Focus on the development of technologically advanced products gives the manufacturers in the orthopedic biomaterials industry an edge over their competitors with increased revenue growth. Such competent treatment offerings provide valuable prospects for the growth of the biomaterials industry. Growing demand for next-generation orthopedic biomaterials for varied orthopedic procedures provides a significant market expansion opportunity globally.

Rising Awareness Campaigns by Government and Private Institutions

Governments around the world and private organizations related to economic and social affairs have increased awareness about the use of orthopedic biomaterials. Clinical trials have created inquisitive interest amongst the masses creating opportunities for investments in the market.

The growing awareness is helpful in expanding the market opportunity to add new consumers. Information delivery of inexpensive orthopedic treatments using biomaterials that provide quick relief to patients provides excellent growth opportunities for the overall orthopedic biomaterials market.

Scope of Orthopedic Biomaterials Market Report

The global orthopedic biomaterials market research report includes an assessment of the market trends, market segments, and regional analysis of markets. Overview and dynamics have also been included in the report.

Orthopedic Biomaterials Market Segment Insights

What Key Factors Contribute to the Rapid Expansion of the Ceramics & Bioactive Glasses Segment?

Increasing Adoption in Hard Tissue Repair Procedures

Based on material segment, the global orthopedic biomaterials market is classified into ceramics & bioactive glasses, metal, calcium phosphate cements, polymers, and others. The ceramics & bioactive glasses segment is expected to expected to dominate the market during the projection period owing to the rapid adoption of ceramics in various procedures for repairing hard tissues. Bioavailability and better efficiency of ceramics & bioactive glass material in orthopedics are expected to boost the segment growth.

Interbody synthesis procedures, joint reconstruction surgeries, and spine reconstruction surgeries make use of ceramics & bioactive glasses implants. Increased use of pedicle screws and synthetic cages for fixation procedures is driving the growth of the segment. Synthetic cages and pedicle screws are used in interbody cages in spinal surgeries that warrant disc removal for interbody fusion procedures. Bioinert ceramics, alumina in specific, are largely preferred in hip arthroplasty and joint arthroplasty.

The polymer segment is anticipated to expand at a rapid pace in the coming years due to their favorable biodegradable properties. According to clinical criteria, implant materials should neither produce bi-products harmful to the human body nor should they be rejected.

Biodegradable polymers from the family of hydroxy esters are used in surgical procedures. They include polyglycolic acid (PGA), polylactic acid (PLA), and copolymers (PLGA). Polymer usage in joint-related orthopedic procedures such as arthroplasties and bone void filling is increasing. The usage in the form of bone cement and load-bearing surfaces is expected to boost segment growth.

What are the Main Aspects Boosting the Orthopedic Implants Segment?

Growing Application in Fixation Procedures

On the basis of application, the market is segmented into bio-resorbable tissue fixation, orthopedic implants, joint replacement/reconstruction, orthobiologics, viscosupplementation, and others. The orthopedic implants segment is expected to expand significantly during the projected period with increasing applications in bone fracture fixations and disc degenerative conditions.

Biomaterials with superior load-bearing surfaces and capacities coupled with high corrosion resistance are in high demand. The high ductility, strength, and wear resistance of biomaterials make them a preferred choice as orthopedic bioimplants.

The orthobiologics segment is predicted projected to grow rapidly in the coming years owing to the increasing number of orthopedic surgeries for bone and joint reconstruction around the world. Orthobiologics are materials derived biologically for regeneration. The rising number of obese patients and increasing incidences of traumatic events are key factors driving the segment.

Orthobiologics procedures help the human body heal faster through the injection of substances by using body cells. Healing of ligament and tendon injuries can be expedited through orthobiologics to protect from osteoarthritis.

What are the Main Aspects for Boosting the Hospitals Segment?

Increasing Orthopedic Ailments of the Rising Geriatric Population

Based on the end-user segment, the market is segmented into specialty clinics, hospitals, and others. The hospitals segment is expected to register a robust growth rate during the forecast period due to bone and joint-related orthopedic procedures. Elderly people require orthopedic biomaterials to be implanted in knee replacements, joints, ligaments, and tendons. Such corrective implanting procedures are possible in hospitals that have boosted segment growth.

The specialty clinics segment is projected to expand rapidly in the coming years owing to the advantages of catering to specific orthopedic ailments of the muscles, joints, and bones. Biomaterials for skeletal, muscle, and tissue diagnostics and engineering are widely used. The use of bone fixation materials made out of biomaterials is growing rapidly which is expected to boost the segment in the forecast period.

Why is North America Dominating the Orthopedic Biomaterials Market?

Increasing Advanced Healthcare Infrastructure

In terms of region, the global orthopedic biomaterials industry is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projected period due to the well-established healthcare infrastructure in North America.

The rising geriatric population of the region for bone disorder treatments and knee replacements. The market of Asia Pacific is anticipated to expand at a rapid pace during the forecast period. The segment growth is attributed to a rise in bone disorders and bone degenerative diseases in middle-income groups of Asia Pacific.

Growing government initiatives for biomaterial usage awareness and rapid expansion of medical facilities are further boosting the market in the Asia Pacific. China has one of the largest markets for joint health care and the market is projected to grow at a significant pace in the in the upcoming years.

Segments

The global orthopedic biomaterials market has been segmented on the basis of

Material

• Ceramics & Bioactive Glasses
• Metal
• Calcium Phosphate Cement
• Polymers
• Others

Application

• Bio-resorbable Tissue Fixation
• Orthopedic Implants
• Joint Replacement/Reconstruction
• Orthobiologics
• Viscosupplementation
• Others

End-user

• Specialty Clinics
• Hospitals
• Others

Region

• Asia Pacific
• North America
• Latin America
• Europe
• Middle East & Africa

Key Players

• Invibio Ltd
• DSM
• Globus Medical
• Zimmer Biomet
• Evonik Industries AG
• Stryker
• Exactech, Inc.
• Smith+Nephew
• Bioventus
• Mitsubishi Chemical America, Inc.
• CAM Bioceramics B.V.
• Heraeus Holding
• Medtronic
• DJO, LLC
• Arthrex, Inc.
• NuVasive®, Inc.

Competitive Landscape

The competitive landscape of the global orthopedic biomaterials market report provides in-depth insights into the growth strategies and development initiatives implemented by the key players in the market.

Key players competing in the orthopedic biomaterials industry are Invibio Ltd; DSM; Globus Medical; Zimmer Biomet; Evonik Industries AG; Stryker; Exactech, Inc.; Smith+Nephew; Bioventus; Mitsubishi Chemical America, Inc.; CAM Bioceramics B.V.; Heraeus Holding; Medtronic; DJO, LLC; Arthrex, Inc. and NuVasive®, Inc.

• On February 10, 2022, DePuy Synthes, an orthopedic unit of US healthcare giant Johnson & Johnson, acquired US-based foot and ankle company CrossRoads Extremity Systems.
• On December 01, 2020, Zimmer Biomet a global solution provider for musculoskeletal disorders based in the US, acquired A&E Medical and its complete portfolio of sternal closure devices that include sternal sutures, cable systems, and rigid fixation along with punch products and pacing wires.